Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSGU) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for BrightSpring Health Services (BTSGU) over the last 3 years, with Q3 2025 value amounting to $140.3 million.

  • BrightSpring Health Services' Cash & Equivalents rose 29013.7% to $140.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.3 million, marking a year-over-year increase of 29013.7%. This contributed to the annual value of $61.0 million for FY2024, which is 36633.0% up from last year.
  • BrightSpring Health Services' Cash & Equivalents amounted to $140.3 million in Q3 2025, which was up 29013.7% from $70.1 million recorded in Q2 2025.
  • In the past 5 years, BrightSpring Health Services' Cash & Equivalents ranged from a high of $140.3 million in Q3 2025 and a low of $13.1 million during Q4 2023
  • Moreover, its 3-year median value for Cash & Equivalents was $55.2 million (2024), whereas its average is $57.0 million.
  • As far as peak fluctuations go, BrightSpring Health Services' Cash & Equivalents skyrocketed by 36633.0% in 2024, and later plummeted by 982.13% in 2025.
  • BrightSpring Health Services' Cash & Equivalents (Quarter) stood at $13.1 million in 2023, then soared by 366.33% to $61.0 million in 2024, then skyrocketed by 130.25% to $140.3 million in 2025.
  • Its last three reported values are $140.3 million in Q3 2025, $70.1 million for Q2 2025, and $52.3 million during Q1 2025.